These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4608286)

  • 1. Clinical evaluation of the antidepressants: maprotiline and amitriptyline. A double-blind controlled trial.
    Marais GF
    S Afr Med J; 1974 Jul; 48(36):1530-2. PubMed ID: 4608286
    [No Abstract]   [Full Text] [Related]  

  • 2. Maprotiline and amitriptyline in the treatment of depressive illness. A double-blind comparison.
    Levin A
    S Afr Med J; 1974 Jan; 48(2):47-9. PubMed ID: 4595136
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled trial of maprotiline (Ludiomil) and amitriptyline in general practice.
    Kay NE; Davies B
    Med J Aust; 1974 May; 1(18):704-5. PubMed ID: 4603998
    [No Abstract]   [Full Text] [Related]  

  • 4. WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients.
    Kaumeier S; Dohren J; Flach D
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):108-13. PubMed ID: 401705
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients.
    Amin M; Brahm E; Bronheim LA; Klingner A; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):691-9. PubMed ID: 4201313
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluotracen (SKF 28, 175): a new antidepressant. Double-blind study with amitriptyline.
    Feldmann HS; Denber HC
    Prog Neuropsychopharmacol; 1980; 4(1):51-6. PubMed ID: 6996019
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A general practitioner double-blind study of dothiepin hydrochloride ('Prothiaden') and amitriptyline in depression.
    Deering RB; Vallé-Jones JC
    Curr Med Res Opin; 1974; 2(8):471-3. PubMed ID: 4614953
    [No Abstract]   [Full Text] [Related]  

  • 9. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 10. Daledalin tosylate: a controlled trial in depressive illness.
    Edwards JG; Ollerenshaw DP
    Curr Med Res Opin; 1974; 2(6):305-12. PubMed ID: 4614944
    [No Abstract]   [Full Text] [Related]  

  • 11. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.
    Wheatley D
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():77-80. PubMed ID: 9342764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zimelidine: a therapeutic and pharmacokinetic study in depression.
    Coppen A; Ramo Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 Jun; 63(3):199-202. PubMed ID: 113803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of amitriptyline and maprotiline in old depressed patients.
    Koncevoj VA; Andrusenko MP; Pjatnickij AN; Kolibás E; Korinkova V; Mayer A
    Act Nerv Super (Praha); 1989 Jun; 31(2):117-8. PubMed ID: 2800942
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the clinical testing of amitriptylin and C 34,276-Ba (dibenzobicyclooctadiene derivative) in a double-blind study].
    Bruck J; Söllner E; Tschabitscher H
    Nervenarzt; 1974 Sep; 45(9):492-6. PubMed ID: 4612394
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical comparative evaluation of maprotiline, a new antidepressant drug. A multicentre study.
    Balestrieri A; Benassi P; Cassano GB; Castrogiovanni P; Catalano A; Colombi A; Conforto C; Del Soldato G; Giberti F; Lucchelli PE; Muratorio A; Nistri M; Sarteschi P
    Int Pharmacopsychiatry; 1971; 6(4):236-48. PubMed ID: 4950566
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled trial of maprotiline (Ludiomil) in depressed outpatients.
    McCallum P; Meares R
    Med J Aust; 1975 Sep; 2(10):392-3. PubMed ID: 1102877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of maprotiline (Ludiomil) and amitriptyline (2).
    Mindham BA
    J Int Med Res; 1977; 5 Suppl 4():25-33. PubMed ID: 338399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amitriptyline N-oxide. A new antidepressant. A clinical double-blind trial in comparison with amitriptyline].
    Godt HH; Fredslund-Andersen K; Edlund AH
    Nord Psykiatr Tidsskr; 1971; 25(3):237-46. PubMed ID: 4945956
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of dothiepin and amitriptyline for the treatment of depression with anxiety.
    Lipsedge MS; Rees WL
    Psychopharmacologia; 1971; 19(2):153-62. PubMed ID: 5565736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.